IMRX · CIK 0001790340 · FY2025 live · 2025-12-31
Immuneering Corp
View as
Model
Classic Z
FY2025
8.03
Zone
Safe
Prior
—
Market DD
—
1y PD
—
Meridian Rank
74.91
0–100 · Classic Z tape · not a PD
Book standing
97
Year change
—
Market PD
—
O-score
16
Events on this name
Same published rows as Today. Not a live recompute.
Approaching grey
watch · 41
- Live Z: — → 8.03
- Cut: — → 1.80
8.03
Z″ 16.03
Score 8.03 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.721.2 × = 0.86X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−1.211.4 × = −1.69X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.263.3 × = −0.84X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
16.180.6 × = 9.71X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Immuneering Corp is on classic Z at 8.03 (safe) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Safe; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 95th percentile in Healthcare.
- KRYSSafeKrystal Biotech, Inc.7.95
- MHUAFSafeMeihua International Medical Technologies Co., Ltd.8.18
- APUSSafeApimeds Pharmaceuticals US, Inc.8.19
- UTHRSafeUNITED THERAPEUTICS Corp8.46
- SIONSafeSionna Therapeutics, Inc.8.47
- SGMTSafeSagimet Biosciences Inc.8.47
- INMDSafeInMode Ltd.8.53
- PMCBSafePharmaCyte Biotech, Inc.7.51
KPI widgets
Current assets
$176M
Total assets
$232M
Current liabilities
$10M
Total liabilities
$14M
Working capital
$166M
Retained earnings
−$280M
EBIT
−$59M
Total sales
$0
Book equity
$218M
Accession 0001790340-26-000042. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.